知镜 Cognispect · 医学文献与研究工作台

A human rheumatoid arthritis bone-cartilage interface organoid recapitulates bone, cartilage, and immune interactions.

Adams M, Grieg C, Gonsiorek W, Wetterstrand C, O'Connor JP, Cottrell J.
Inflammation and regeneration · 2026-08-08 · PMID 42983776

文献摘要

Background Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation, cartilage degradation, and bone erosion. Fibroblast-like synoviocytes (FLS) play a central role in perpetuating joint damage, yet current therapies inadequately address FLS-driven pathology. Existing preclinical models, including murine collagen-induced arthritis and conventional in vitro cultures, lack the complexity to fully recapitulate human disease mechanisms. Methods Here, we describe the development of a three-dimensional (3D) RA bone-cartilage interface (BCI) organoid that integrates primary human mesenchymal stem cell-derived osteoblasts, peripheral blood mononuclear cell-derived osteoclasts and lymphocytes, immortalized human chondrocyte spheroids, and the RA synovial fibroblast cell line SW982. Results Exposure to TNF-α, IL-1β, and TGF-β induced pro-inflammatory cytokines, matrix-degrading enzymes, and increased fibrotic gene expression, accompanied by histological and microCT evidence of bone dysregulation. Therapeutic testing showed that methotrexate, etanercept, and tofacitinib reduced cytokine production and pro-inflammatory gene expression but had limited impact on profibrotic gene expression. Conclusions This modular, human-derived RA BCI organoid reproduced key features of RA pathogenesis that can enable direct assessment of therapeutic mechanisms at the bone-cartilage-synovial interface. The RA BCI organoid provides a physiologically relevant, scalable platform for preclinical drug discovery and for identifying combination strategies that address both the inflammatory and fibrotic components of RA pathology.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。